Literature DB >> 14510638

Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism.

Andelko Hrzenjak1, Sasa Frank, Xingde Wo, Yonggang Zhou, Theo Van Berkel, Gert M Kostner.   

Abstract

Lp(a) [lipoprotein (a)] is a highly atherogenic plasma lipoprotein assembled from low-density lipoprotein and the glycoprotein apolipoprotein (a). The rate of Lp(a) biosynthesis correlates significantly with plasma Lp(a) concentrations, whereas the fractional catabolic rate does not have much influence. So far, little is known about Lp(a) catabolism. To study the site and mode of Lp(a) catabolism, native or sialidase-treated Lp(a) was injected into hedgehogs or ASGPR (asialoglycoprotein receptor)-knockout (ASGPR-) mice or wild-type (ASGPR+) mice, and the decay of the plasma Lp(a) concentration was followed. COS-7 cells were transfected with high- (HL-1) and low-molecular-mass ASGPR subunits (HL-2), and binding and degradation of intact or desialylated Lp(a) were measured. In hedgehogs, one of the few species that synthesize Lp(a), most of the Lp(a) was taken up by the liver, followed by kidney and spleen. Lp(a) and asialo-Lp(a) were catabolized with apparent half-lives of 13.8 and 0.55 h respectively. Asialo-orosomucoide increased both half-lives significantly. In mice, the apparent half-life of Lp(a) was 4-6 h. Catabolism of native Lp(a) by wild-type mice was significantly faster compared with ASGPR- mice and there was a significantly greater accumulation of Lp(a) in the liver of ASGPR+ mice compared with ASGPR- mice. The catabolism of asialo-Lp(a) in ASGPR- mice was 8-fold faster when compared with native Lp(a) in wild-type mice. Transfected COS-7 cells expressing functional ASGPR showed approx. 5-fold greater binding and 2-fold faster degradation of native Lp(a) compared with control cells. Our results for the first time demonstrate a physiological function of ASGPR in the catabolism of Lp(a).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510638      PMCID: PMC1223821          DOI: 10.1042/BJ20030932

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  In vivo studies on the binding sites for lipoprotein (a) on parenchymal and non-parenchymal rat liver cells.

Authors:  L Harkes; G Jürgens; A Holasek; T J van Berkel
Journal:  FEBS Lett       Date:  1988-01-18       Impact factor: 4.124

2.  HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Authors:  G M Kostner; D Gavish; B Leopold; K Bolzano; M S Weintraub; J L Breslow
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

3.  The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes.

Authors:  T J van Berkel; J K Kruijt; H H Spanjer; J F Nagelkerke; L Harkes; H J Kempen
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

4.  Molecular characterization of the rat Kupffer cell glycoprotein receptor.

Authors:  Andrew J Fadden; Oliver J Holt; Kurt Drickamer
Journal:  Glycobiology       Date:  2003-04-02       Impact factor: 4.313

5.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

6.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

Authors:  R C Pittman; T E Carew; C K Glass; S R Green; C A Taylor; A D Attie
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

7.  Two galactose-specific receptors in the liver with different function.

Authors:  P H Roos; V Kolb-Bachofen; J Schlepper-Schäfer; M Monsigny; R J Stockert; H Kolb
Journal:  FEBS Lett       Date:  1983-07-04       Impact factor: 4.124

8.  Turnover of lipoprotein (a) in man.

Authors:  F Krempler; G M Kostner; K Bolzano; F Sandhofer
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

9.  Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor.

Authors:  K Maartmann-Moe; K Berg
Journal:  Clin Genet       Date:  1981-11       Impact factor: 4.438

10.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a).

Authors:  G M Fless; M E ZumMallen; A M Scanu
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

View more
  13 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).

Authors:  Calvin Yeang; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2015-05-26       Impact factor: 5.922

Review 3.  Lipoprotein (a): a historical appraisal.

Authors:  Karam M Kostner; Gert M Kostner
Journal:  J Lipid Res       Date:  2016-11-07       Impact factor: 5.922

Review 4.  Lipoprotein(a) metabolism: potential sites for therapeutic targets.

Authors:  Jane Hoover-Plow; Menggui Huang
Journal:  Metabolism       Date:  2012-10-04       Impact factor: 8.694

5.  Lipoprotein(a): biology and clinical importance.

Authors:  Sally P A McCormick
Journal:  Clin Biochem Rev       Date:  2004-02

6.  Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Authors:  Monika Sharma; Anne Von Zychlinski-Kleffmann; Carolyn M Porteous; Gregory T Jones; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2015-04-06       Impact factor: 5.922

7.  ASGR1 - a new target for lowering non-HDL cholesterol.

Authors:  Mohamed Hassan; Kerolos Wagdy
Journal:  Glob Cardiol Sci Pract       Date:  2016-06-30

Review 8.  Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease.

Authors:  Hayato Tada; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2019-04-30       Impact factor: 4.928

9.  Cell release during perfusion reflects cold ischemic injury in rat livers.

Authors:  Reinier J de Vries; Casie A Pendexter; Stephanie E J Cronin; Beatriz Marques; Ehab O A Hafiz; Alona Muzikansky; Thomas M van Gulik; James F Markmann; Shannon L Stott; Heidi Yeh; Mehmet Toner; Korkut Uygun; Shannon N Tessier
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

Review 10.  Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.

Authors:  Motasim M Jawi; Jiri Frohlich; Sammy Y Chan
Journal:  J Lipids       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.